ArticleFrontiers in endocrinology2025
Development and validation of a nomogram model for prediction of dyslipidemia in children with Wilson disease: a retrospective analysis.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Wilson disease (WD), an inherited copper metabolism disorder, is linked to hepatic injury from copper accumulation-induced dyslipidemia. Children with WD have a high incidence of dyslipidemia, yet personalized risk assessment tools are lacking. This study established a predictive nomogram to provide foundational evidence for early detection in this population. Methods: In this retrospective cohort study, clinical data from 913 children with WD were retrospectively collected at the First Affiliated Hospital of Anhui University of Chinese Medicine (November 2018-February 2025). The cohort was stratified by age group and dyslipidemic status using stratified random sampling, resulting in a division into a training set (70%, Results: The prevalence of dyslipidemia was 68.24%. The nomogram incorporated six significant clinical variables: age group (≥ 10 years vs. < 10 years), alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (GGT), homocysteine (Hcy), superoxide dismutase (SOD), and platelet count (PLT). The prediction model demonstrated good discrimination (AUC: 0.810 in the training set, 0.831 in the validation set), excellent calibration (Hosmer-Lemeshow Conclusion: Children with WD exhibit a high incidence of dyslipidemia. The nomogram prediction model based on these six variables effectively predicts dyslipidemic risk in pediatric WD patients, enabling early identification and clinical risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.